News

Capricor Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) plans to convene a panel of outside experts ...
From STAT’s Adam Feuerstein: The FDA informed Capricor Therapeutics that a meeting of outside experts will be convened to ...
The FDA has rehired at least some workers tasked with releasing public records generated by the agency’s regulatory ...
The FDA’s user free programs account for just under half of the agency’s budget—money that could be imperiled by the recent ...
The FDA is asking some of its recently fired staff responsible for critically important funding negotiations with drugmakers ...
Under the current expiring user fee agreements, the FDA commits to complete new drug approval reviews within either 10 months ...
Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...
For the second time in recent months, the Food and Drug Administration is bringing back some recently fired employees, ...
The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...
BHVN's Troriluzole awaits pivotal FDA approval in 2025, backed by $600M funding. Explore its diverse pipeline and promising ...
Initial study results for ISB 2001, which treats relapsed or refractory multiple myeloma, demonstrated a high overall ...